The nation’s first hydrogen-powered passenger train will begin operations Saturday, Sept. 13, on Metrolink’s Arrow line between Redlands and San Bernardino. The San Bernardino County Transportation ...

FOXBOROUGH — Any time there are four new starters on an offensive line, there are bound to be growing pains, especially with a pair of rookies side-by-side on the left side. But that’s the reality the ...

JOHNSON CITY, Tenn. (WJHL) — Johnson City Water and Sewer Services will perform water line maintenance on a portion of Buffalo Street starting Thursday. Southbound lane closures on Buffalo Street ...

Apple this week announced a huge collection of new products, and today we're already tracking a few notable offers you can get when pre-ordering select devices. Highlights include $20 in Best Buy ...

India Today offers an exclusive first look at Apple's latest iPhone 17 Pro models, highlighting its design and key features. Vande Bharat passenger's ‘lack of civic sense' post sparks debate on Reddit ...

Psychiatrists and mental health professionals have always relied on medication and talk therapy to treat depression, but Dr. Nicholas Fabiano, a psychiatry resident at the University of Ottawa, thinks ...

All products featured here are independently selected by our editors and writers. If you buy something through links on our site, Mashable may earn an affiliate commission. Apple took its time ...

It’s been two years since we’ve gotten a new pair of AirPods Pro, but it feels like a lot longer. The last iteration, the AirPods Pro 2, was a refresh in 2023, but it was just a refresh. The ...

Rancilio has long been synonymous with quality and durability in the espresso machine world, bridging the gap between commercial-grade performance and home use. This analysis delves into the nuances ...

(Barcelona, Spain-- September 8, 2025 at 5:00 PM CEST / UTC +2)— Clinical data presented today demonstrates the combination of tarlatamab with anti-PD-L1 therapy as first-line maintenance has an ...

Clinical data demonstrate the combination of tarlatamab with anti-PD-L1 therapy as first-line maintenance has an acceptable safety profile and resulted in unprecedented overall survival in patients ...